Soreide Law Group is investigating possible investor claims against securities broker Erkan Eric Afacan (CRD: 2563297, Paramus, New Jersey). Evidently, Cambridge Investment Research Inc. permitted Afacan to resign amid allegations of his misconduct. Here is a brief summary of Cambridge Investment Research Inc.’s and investors’ allegations against Afacan.
Cambridge Investment Research Inc. Terminates Afacan For Violation Of Policy
Afacan worked for Cambridge Investment Research Inc. in Paramus, New Jersey, as a securities broker from January 3, 2007, to October 28, 2022. Supposedly, on September 30, 2022, Cambridge Investment Research Inc. disaffiliated with Afacan. Evidently, Cambridge Investment Research Inc. alleged that Afacan covered account losses in violation of company policy.
Erkan Afacan Discloses Unsuitable Recommendations Allegations By Cambridge Investment Research Inc. Client
Evidently, a client of Cambridge Investment Research Inc. contested Erkan Afacan’s sales practices by filing FINRA Arbitration: 15-01807. Allegedly, Afacan gave unsuitable advice. It appears that Afacan caused the client to sustain damages on BDCs. Therefore, Cambridge Investment Research Inc. opted to settle the matter on November 14, 2016, by compensating the client in the amount of $40,000.
UBS Financial Services Inc. Investor Accuses Afacan Of Misrepresentation
Supposedly, on July 7, 2003, a UBS Financial Services Inc. client filed a complaint about Erkan Afacan. Namely, the client alleged that Afacan made misrepresentations. Because of this, the client allegedly sustained damages on variable annuities. Therefore, the client requested compensation from UBS Financial Services Inc. or Afacan. However, the securities firm denied this complaint.
Damages Resulting From Cambridge Investment Research Inc. Securities Broker Erkan Afacan?
Suffer damages because of Erkan Afacan? If so, reach out to Soreide Law Group at (888) 760-6552 and talk with a securities attorney about a possible recovery of your losses. Soreide Law Group, who has effectively recovered money for investors throughout the United States, represents investors on a contingency fee basis and advances costs. Afacan and brokerage firms Afacan worked for deny accusations against them.